Loading data for REVBW — first visit, this takes a few seconds.
Revelation Biosciences In... (REVBW)
: REVBW
· 실시간 가격 · USD
n/a
n/a (n/a)
종가 기준: Invalid Date
주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.
Revelation Biosciences Inc.(REVBW) 주가, 분석 및 데이터
데이터 없음
REVBW 소개
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the ...
전체 기업 정보재무 실적
2025년 Revelation Biosciences의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -8.91M로, -40.73% 감소했습니다.
재무제표